Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPlb-dependent process, defective in Bernard-Soulier syndrome

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 170-176

  Beguin S ^a   Keularts, I ^a   Al Dieri, R ^a   Bellucci, S ^b   Caen, J ^c   Hemker, H C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Academie des Sciences   (France)

Author keywords

Fibrin; GPIb; Platelets; Thrombin generation; VWF

Indexed keywords

ENZYME; FIBRIN; FIBRINOPEPTIDE A; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PROCOAGULANT; RISTOCETIN; SNAKE VENOM; THROMBIN; VON WILLEBRAND FACTOR; BIOPOLYMER; THROMBIN RECEPTOR;

ADULT; ARTICLE; BERNARD SOULIER DISEASE; CASE REPORT; CELL DAMAGE; CONTROLLED STUDY; FEMALE; FIBRIN POLYMERIZATION; HUMAN; HUMAN CELL; HYPOTHESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; THROMBOCYTE ADHESION; THROMBOCYTE RICH PLASMA; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; CHEMISTRY; GENETICS; IN VITRO STUDY; METABOLISM; MIDDLE AGED; THROMBOCYTE;

BERNARD-SOULIER SYNDROME; BIOPOLYMERS; BLOOD PLATELETS; FEMALE; FIBRIN; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; THROMBIN; VON WILLEBRAND FACTOR;

EID: 3242727059     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00558.x     Document Type: Article

References (49)

1. Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-9.
2. Bevers EM, Comfurius P, van Rijn JLML, Hemker HC, Zwaal RFA. Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
3. Bevers EM, Comfurius P, Zwaal RFA. Mechanisms involved in platelet procoagulant response. Adv Exp Med Biol 1993; 344: 195-207.
4. Jamieson GA. Pathophysiology of platelet thrombin receptors. Thromb Haemost 1997; 78: 242-6.
5. Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non Thrombotic Disorders. Pathophysiology, Pharmacology and Therapeutics. Cambridge: Cambridge University Press, 2002: 727-37.
6. Dicker IB, Pedicord DL, Seiffert DA, Jamieson GA. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Thromb Haemost 2001; 86: 1065-9.
7. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-78.
8. Kumar R, Béguin S, Hemker HC. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 1995; 74: 962-8.
9. Béguin S, Kumar R. Thrombin, fibrin and platelets. A resonance loop in which von Willebrand factor is a necessary link (published erratum, 1997; 78: 973). Thromb Haemost 1997; 78: 590-4.
10. Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-70.
11. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Chacterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-61.
12. 2+] induced by alpha-thrombin. Biochemistry 1996; 35: 906-14.
13. 2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide. Biochemistry 1996; 35: 915-21.
14. Miyata S, Goto S, Federici AB, Ware J, Ruggeri ZM. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha. J Biol Chem 1996; 271: 9046-53.
15. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1: 1335-42.
16. Bernard J, Soulier JP. Sur une nouvelle variété de dystrophic thrombocytaire hémorragipare congénitale. Semin Hop Paris 1948; 24: 3217.
17. Caen JP, Bellucci S. The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. Blood Cells 1983; 9: 389-99.
18. Nurden AT, Caen JP. Specific roles for surface glycoprotein in platelet function. Nature 1975; 255: 720-2.
19. Bellucci S, Girma JP, Lozano M, Meyer D, Caen JP. Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIII. Thromb Haemost 1997; 77: 383-6.
20. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91: 4397-418.
21. Nurden AT, Nurden P. Inherited defects of platelet function. Rev Clin Exp Hematol 2001; 5: 314-418.
22. Bevers EM, Comfurius P, Nieuwenhuis HK, Levy-Toledano S, Esnouf J, Belluci S, Caen JP, Zwaal RF. Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol 1986; 63: 335-45.
23. Perret B, Lévy-Toledano S, Plantavid M, Bredoux R, Chap H, Tobelem G, Douste-Blazy L, Caen JP. Abnormal phospholipid organization in Bernard-Soulier platelets. Thrombosis Res 1983; 31: 529-37.
24. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 589-91.
25. Hemker HC, Giesen PLA, Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophys Haemost Thromb 2003; 33: 2-3.
26. Yukelson LY, Tans G, Thomassen MC, Hemker HC, Rosing J. Procoagulant activities in venoms from central Asian snakes. Toxicon 1991; 29: 491-502.
27. Discipio RG, Hemodson MA, Yates SG, Davies EW. A comparison of human prothrombin, factor IX (Christmas factor), factor XS (Stuart factor) and protein S. Biochemistry 1977; 16: 698-706.
28. Hendrix H, Lindhout T, Mertens K, Hengels W, Hemker HC. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem 1983; 258: 3637-44.
29. Coller BS, Peersche EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
30. Edgell T, McEvoy F, Webbon P, Gaffney PJ. Monoclonal antibodies to human fibrin: interaction with other animal fibrins. Thromb Haemost 1996; 75: 595-9.
31. 2+-ATPase in calcium responses of single, fibrinogen-bound platelets. J Biol Chem 1993; 268: 356-63.
32. Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the pro-thrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56 9-17.
33. Walsh PN, Mills DC, Pareti FI, Stewart GJ, Macfarlane DE, Johnson MM, Egan JJ. Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol 1975; 29: 639-55.
34. De Marco L, Mazzucato M, Masotti A, Fenton JWD, Ruggeri ZM. Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 1991; 266: 23776-83.
35. Jamieson GA, Okumura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978; 61 861-4.
36. Liu L, Freedman J, Hornstein A, Fenton JWII, Song Y, Ofusu FA. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation. J Biol Chem 1997; 272: 1997-2004.
37. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the sub-endothelium. Nature 1979; 279 636-8.
38. Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor. Br J Pharmacol 1997; 122: 165-71.
39. Endenburg SC, Hantgan RR, Sixma JJ, de Groot PG, Zwaginga JJ. Platelet adhesion to fibrin(ogen). Blood Coagul Fibrinolysis 1993; 4: 139-42.
40. Endenburg SC, Hantgan RR, Lindeboom-Blokzijl L, Lankhof H, Jerome WG, Lewis JC, Sixma JJ, de Groot PG. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood 1995; 86: 4158-65.
41. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
42. Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345-53.
43. Parker RI, Gralnick HR. Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein Ib. Blood 1987; 70: 1589-94.
44. Loscalzo J, Inbal A, Handin RI. Von Willebrand protein facilitates platelet incorporation into polymerizing fibrin. J Clin Invest 1986; 78: 1112-9.
45. Briede JJ, Wielders SJ, Heemskerk JW, Baruch D, Hemker HC, Lindhout T. von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets. J Thromb Haemost 2003; 1: 559-65.
46. Soslau G, Class R, Morgan DA, Foster C, Lord ST, Marchese P, Ruggeri ZM. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-83.
47. Baglia FA, Badellino KO, Li CQ, López JA, Walsh PN. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 2002; 18: 1662-8.
48. Keularts IM, Zivelin A, Seligsohn U, Hemker HC, Béguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85: 1060-5.
49. Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to sub-endothelium: a defect in platelet spreading. Blood 1986; 68: 692-5.